Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium and CoQ10 in Heart Failure
NCT07234422Phase 3Recruiting
- Sponsor
- Netherlands Heart Institute
- Start
- May 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) (2 arms), sponsored by Netherlands Heart Institute. Primary endpoint: Composite of repeated HF hospitalization, repeated urgent HF visits and cardiovascular death at 30 months. Started May 2026; status: recruiting.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07234422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07234422.